Abstract: BACKGROUND: Lateral epicondylitis, also known as 'tennis elbow' is a degenerative disorder of the common extensor origin of lateral epicondyle of humerus, first described by Runge in 1883. The annual prevalence of lateral epicondylitis is reported between 1 to 3 % among normal non-athlete population. The mainstay of treatment is non-operative and includes rest, activity or equipment modification, non-steroidal anti-inflammatory medications, bracing, and physical therapy like extracorporeal shock wave therapy. However, these traditional therapies do not alter the tendon's inherent poor healing.....
KEYWORD: Platelet rich plasma, tennis elbow, patient rated tennis elbow evaluation (prtee), visual analogue scale (vas), quick dash (disability of arm and shoulder) score
[1]. Runge F. For the genesis and treatment of the writing crane. Bed KlinWorchenschr. 1873; 10:245-24.
[2]. Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C. Prevalence andimpact of musculoskeletal disorders of the upper limb in the generalpopulation. Arthritis Rheum 2004; 51:642–51.
[3]. Krogh TP, Fredberg U, Stengaard-Pedersen K, Christensen R, Jensen P, Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. Am J Sports Med.2013;41(3):625–635 [Internet].
[4]. Kahlenberg CA, Knesek M, Terry MA. New developments in the use of biologics and other modalities in the management of lateral epicondylitis. Biomed Res Int. 2015; 2015:439309 [Internet]. Hindawi Publishing Corporation.
[5]. Regan W, Wold LE, Coonrad R, Morrey BF. Microscopic histopathology of chronic refractory lateral epicondylitis. Am J Sports Med. 1992;20(6):746-9.